Skip to main content
Fig. 4 | Breast Cancer Research

Fig. 4

From: Circulating tumor DNA as a dynamic biomarker of response to palbociclib and fulvestrant in metastatic breast cancer patients

Fig. 4

ctDNA dynamics correlation with treatment response. a ctDNA concentrations at the 4 sampling time points in patients with non-progressive disease (green) versus patients with progressive disease (red) after 3 months of palbociclib-fulvestrant. Black lines refer to median values. ctDNA variation in patients with non-progressive disease (b) or progressive disease (c) during treatment follow-up. Each patient is highlighted with a unique color. Bsl, baseline; D15, day 15; D30, day 30; Progr., disease progression; PD, progressive disease

Back to article page
\